Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197872 · ClinicalTrials.gov registry record
Clinical Use of Parental Support To Detect Single Gene Mutations
A clinical trial, sponsored by Natera.
- Completed
- Registry status
- 240
- Enrollment target
NCT01197872 is a clinical trial that has completed, run by Natera. The registered enrollment target is 240 participants.
The verdict
NCT01197872 has completed, sponsored by Natera.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
Gene Security Network has developed a novel technology called Parental Support (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the best chance of developing into healthy children.
Interventions
- OTHER Preimplantation Genetic Diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197872
The ClinicalTrials.gov registry entry for NCT01197872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preimplantation Genetic Diagnosis is the first listed.
NCT01197872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197872 about?
NCT01197872 is a clinical study titled "Clinical Use of Parental Support To Detect Single Gene Mutations". Gene Security Network has developed a novel technology called Parental Support (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the be...
What is the current status of trial NCT01197872?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2010-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01197872?
The interventions under investigation include: Preimplantation Genetic Diagnosis (OTHER).
Who is sponsoring clinical trial NCT01197872?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.